跳至主要内容
临床试验/JPRN-UMIN000005237
JPRN-UMIN000005237尚未招募未知

Randomized controlled trial to determine the efficacy and safety of ramosetron hydrochloride in male patients with diarrheal-predominant IBS symptom - Randomized controlled trial of the effect of ramosetron hydrochloride on IBS symptom

Department of Hepatology and Pancreatology, Kyushu University Hospital0 个研究点目标入组 60 人开始时间: 2011年5月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1) Patients who have bowel move disturbance by organic lesion such as IBD(UC and crohn disease etc.) and cancer. 2) Patients suspected of obstruction in stomach and intestines, and with a history of total gastric resection or bowel resection but not appendicectomy 3) Patients with serious complications (liver, kidney, heart, lung, circulatory, or metabolic disorder) 4) Patients with a history of drug allergy 5) Patients who are taking psychotropic drug 6) Others, including patients who are unfit for the study as determined by the attending doctor

研究者

发起方
Department of Hepatology and Pancreatology, Kyushu University Hospital

相似试验